E2 Represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 119-126

  Stubenrauch, F ^a   Leigh, I M ^b   Pfister, H ^c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; VIRUS CELL INTERACTION; WART VIRUS;

ANIMAL; BASE SEQUENCE; BINDING SITES; CATTLE; CELL LINE; DNA, VIRAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMAN; KERATINOCYTES; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS, HUMAN; PROMOTER REGIONS (GENETICS); RABBITS; REPRESSOR PROTEINS; SUPPORT, NON-U.S. GOV'T; TATA BOX; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTORS; TRANSFECTION; VIRAL PROTEINS;

EID: 0029655756     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.119-126.1996     Document Type: Article

References (44)

1. Androphy, E. J., D. R. Lowy, and J. T. Schiller. 1987. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature (London) 325:70-73
2. Barsoum, J., S. S. Prakash, P. Han, and E. J. Androphy. 1992. Mechanism of action of the papillomavirus E2 repressor: repression in the absence of DNA binding. J. Virol 66:3941-3945
3. Bernard, B. A., C. Bailly, M.-C. Lenoir, M. Darmon, F. Thierry, and M. Yaniv. 1989. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol. 63:4317-4324.
4. Bouvard, V., A. Storey, D. Pim, and L. Banks. 1994. Characterization of the human papillomavirus E2 protein: evidence for trans-activation and trans-repression in cervical keratmocytes. EMBO J. 13:5451-5459.
5. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction Anal. Biochem. 162:156-159
6. Demeret, C., M. Yaniv, and F. Thierry. 1994. The E2 transcriptional repressor can compensate for SP1 activation of the human papillomavirus type 18 early promoter J. Virol 68:7075-7082.
7. Dong, G., T. R. Broker, and L. T. Chuw. 1994. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol. 68:1115-1127.
8. Dong, X.-P., F. Stubenrauch, E. Beyer-Finkler, and H. Pfister. 1994. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int. J. Cancer 58:803-808.
9. Dostatni, N., P. F. Lambert, R. Sousa, J. Ham, P. M. Howley, and M. Yaniv. 1991 The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex Genes Dev. 5:1657-1671
10. Ensser, A., and H. Poster. 1990 Epidermodysplasia verruciformis associated human papiliomaviruses present a subgenus-specific organization of the regulatory genome region. Nucleic Acids Res. 11:3919-3922
11. Fuchs, P. G., S. Horn, T. Iftner, M. May, F. Stubenrauch, and H. Pfister. 1993. Molecular biology of epidermodysplasia verruciformis-associated human papillomaviruses, p. 517-529. In W. Doerfler and P. Bohm (ed.), Virus strategies. Verlag Chemie, Weinheim, Germany.
12. Fuchs, P. G., and H. Pfister. 1994. Transcription of papillomavirus genomes. Intervirology 37:159-167
13. Fuchs, P. G., J. Weninger, T. Iftner, and H. Poster. 1986. Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis. J. Virol. 58:626-634.
14. Ham, J., N. Dostatni, J. M. Gauthier, and M. Yaniv. 1991. The papillomavirus E2 protein: a factor with many talents. Trends Biol. Sci. 16:440-444.
15. Ham, J., G. Steger, and M. Yaniv. 1994. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. EMBO J. 13:147-157.
16. Haugen, T. H., L. P. Turek, F. M. Mercurio, T. P. Cripe, B. J. Olson, R. D. Anderson, D. Seidl, M. Karin, and J. Schiller. 1988. Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 transactivator require an N-terminal amphipathtc helix-containing E2 domain EMBO J. 7:4245-4253.
17. Hawley-Nelson, P., E. J. Androphy, D. R. Lowy, and J. T. Schiller. 1988. The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. EMBO J. 7:525-531.
18. Hermonat, P. L., B. A. Spalholz, and P. M. Howley. 1988. The bovine papillomavirus P2443 promoter is E2 trans-responsive: evidence for E2 autoregulation EMBO J. 7:2815-2822.
19. Horn, S., H. Pfister, and P. G. Fuchs. 1993. Constitutive transcriptional activator of epidermodysplasia verruciformis-associated human papillomavirus 8. Virology 196:674-681.
20. Krubke, J., J. Kraus, H. Delius, L. T. Chow, T. R. Broker, T. Iftner, and H. Pfister. 1987. Genetic relationship among human papillomaviruses associated with benign and malignant tumours of patients with epidermodysplasia verruciformis. J. Gen. Virol. 68:3091-3103.
21. Lambert, P. F., B. A. Spalholz, and P. M. Howley. 1987 A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator. Cell 50:69-78.
22. Lees, E., K. Osborn, L. Banks, and L. Crawford. 1990. Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein. J. Gen. Virol. 71:183-193
23. Luckow, B., and G. Schütz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
24. May, M., X.-P. Dong, E. Beyer-Finkler, F. Stubenrauch, P. G. Fuchs, and H. Pfister. 1994. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from repression by mutation of target sequences for YY1. EMBO J. 13:1460-1466
25. May, M., K. Grassmann, H. Pfister, and P. G. Fuchs. 1994. Transcriptional silencer of the HPV8 late promoter interacts alternatively with viral E2 or a cellular protein. J. Virol. 68:3612-3619
26. May, M., V. Helbl, H. Pfister, and P. G. Fuchs. 1991. Unique topography of DNA-protein interactions in the non-coding region of epidermodysplasia verruciformis-associated human papillomaviruses, J. Gen. Virol 72:2989-2997.
27. McBride, A. A., J. C. Byrne, and P. M. Howley. 1989. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: trans-activation is mediated by the conserved amino-terminal domain. Proc Natl. Acad. Sci. USA 86:510-514.
28. McBride, A. A., H. Romanczuk, and P. M. Howley. 1991. The papillomavirus E2 regulatory proteins. J. Biol. Chem. 266:18411-18414.
29. McBride, A. A., R. Schlegel, and P. M. Howley. 1988. The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity. EMBO J. 7:533-539.
30. Monini, P., I. L. Blitz, and E. Cassai. 1993. Cooperative DNA binding of the bovine papillomavirus E2 transcriptional activator is antagonized by truncated E2 polypeptides. J. Virol. 67:5668-5676.
31. Nasseri, M., J. R. Gage, A. Lorincz, and F. O. Wettstein. 1991 Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7 and E2 initiated at the P97 promoter and express high levels of E7. Virology 184:131-140.
32. Pfister, H. 1992. Human papillomaviruses and skin cancer. Semin Cancer Biol. 3:263-271.
33. Purdie, K. J., C. J. Sexton, C. M. Proby, M. T. Glover, A. T. Williams, K. J. Stables, and I. M. Leigh. 1993 Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res 53:5328-5333.
34. 105 promoters. J. Virol. 64:2849-2859.
35. Rotenberg, M. O., C.-M. Chiang, M. L. Ho, T. R. Broker, and L. T. Chow. 1989. Characterization of cDNAs of spliced HPV-11 E2 mRNA and other HPV mRNAs recovered via retrovirus-mediated gene transfer. Virology 172:468-477.
36. Sealey, L., and R. Chalkley. 1987. At least two nuclear proteins bind specifically to the Rous sarcoma virus long terminal repeat Mol. Cell Biol. 7:787-798.
37. Stenlund, A., and M. R. Botchan. 1990. The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes Dev. 4:123-136.
38. Stubenrauch, F., J. Malejczyk, P. G. Fuchs, and H. Pfister. 1992. Late promoter of human papillomavirus type 8 and its regulation. J. Virol 66: 3485-3493.
39. Stubenrauch, F., and H. Pfister. 1994 Low-affinity E2-binding site mediates down modulation of E2 transactivation of the human papillomavirus type 8 late promoter. J. Virol. 68:6959-6966.
40. Szymanski, P., and A. Stenlund. 1991. Regulation of early gene expression from the bovine papillomavirus genome in transiently transfected C127 cells. J Virol. 65:5710-5720.
41. Tan, S.-H., B. Gloss, and H.-U. Bernard. 1992 During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res 20:251-256.
42. Tan, S.-H., L. E.-C. Leong, P. A. Walker, and H.-U. Bernard. 1994. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 68:6411-6420.
43. Ushikai, M., M. J. Lace, Y. Yamakawa, M. Kono, J. Anson, T. Ishiji, S. Parkinnen, N. Wicker, M.-E. Valentine, I. Davidson, L. P. Turek, and T. H. Haugen. 1994. trans. activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. J. Virol. 68:6655-6666.
44. Vande Pol, S. B., and P. M. Howley. 1990. A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor J. Virol 64:5420-5429.